Our Team

A strong committed leadership focused on advancing the future of pain management

Galit Zuckerman Stark

Founder, CEO and board member

Ms. Zuckerman Stark brings to Medasense over twenty years of entrepreneurship, management and engineering experience in both start-ups and large corporations. Ms. Zuckerman Stark founded Medasense upon discovering that while advanced algorithms are used frequently in many different industries such as semiconductors, communication, and many others, the discipline of medicine and specifically pain was still left behind....

Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Ms. Zuckerman started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.

Ms. Zuckerman Stark holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.

Walter Tabachnik

CFO AND BOARD MEMBER

Mr. Tabachnik served as the Executive Vice President and Chief Financial Officer of Oridion Systems, a successful patient monitoring company. He led their successful acquisition by the global healthcare company, Covidien, for $346M in 2012. Mr. Tabachnik later served as Covidien’s Director of Strategy and Portfolio EMEA....

Previously Mr. Tabachnik has held a number of senior accounting positions in various distinguished firms in Israel and South Africa. Mr. Tabachnik is a Certified Public Accountant in Israel and holds a BA in Accounting and Economics from the Hebrew University of Jerusalem, Israel.

Adi Costa

VP Research and Development

Mr. Costa brings over a decade of experience in algorithm and software development combined with strong practical knowledge of the clinical and regulatory R&D process. As VP R&D for Paieon Medical, a medical device startup in the field of cardiac imaging diagnostics, he led the design and development of their algorithm and software technology, and successfully managed the technical aspects of their clinical and regulatory process....

He was previously the Algorithm Group Manager for Applied Materials where he developed several unique Intellectual Property solutions with patents filed and his work published. Prior to this, he has held software engineering roles for Demantra-Oracle and Idioma.

Mr. Costa holds an MSc in Computer Sciences from Bar-Ilan University, Israel.

Mira Altmark-Sofer

VP Business Development & Marketing

Ms. Sofer (EMBA) brings over fifteen years of experience in building commercial and marketing strategy, and developing new business channels. Prior to joining Medasense, Ms. Sofer was the VP Business Development and Marketing at Medisim Ltd., a developer and manufacturer of sophisticated thermometry medical devices....

She led the trade and sales activity in the U.S. and Europe and was responsible for the strategic business partnerships. She has also held various business development and marketing leadership positions for Ophir Group and Promarket.

Ms. Sofer served as an outside director of a public company and holds an EMBA from the Recanati Business School – Tel Aviv University

Rachel Weissbrod

VP Clinical, Regulatory and QA Affairs

Ms. Weissbrod brings twenty years of experience in the medical device industry in clinical strategy and market development, regulatory affairs and quality assurance, product innovation and management. Prior to joining Medasense, Ms. Weissbrod was a Global Director of Medical Affairs & Value Based Healthcare at Medtronic focusing on clinical market development for patient monitoring devices....

Ms. Weissbrod has held leadership roles in Quality Assurance, Regulatory & Clinical Affairs at Covidien, Oridion Medical and additional start-up companies with extensive experience in leading teams in the development and execution of global regulatory, quality and clinical strategies supporting new product development and commercialization.

Ms. Weissbrod holds a B.Pharm, and an MBA, both from the Hebrew University, Jerusalem, Israel.